ClinicalTrials.gg
Not yet recruitingNCT07842588Updated Nov 6, 2026

Examining the Relationship Between Ongoing Alcohol Use, Suicidal Thoughts and Behaviors and Related Constructs, and Behavioral Economic Decision-Making.

An interventional study of CBT4CBT in Alcohol Use Disorder (AUD) and Suicidal Ideation, sponsored by Mark J Rzeszutek, PhD. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Mark J Rzeszutek, PhD · Not applicable, Interventional, and Treatment

Updated Nov 6, 2026Primary outcomes revisedNewly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will evaluate the relationship between alcohol use, suicidal thoughts and behaviors, and behavioral economic decision-making. Participants will complete surveys over approximately 12 weeks and will be randomly assigned to receive access to a self-guide computerized cognitive behavioral therapy (CBT4CBT) program either immediately or after a waiting period. The study will compare participants with and without recent suicidal thoughts and behaviors to better understand factors associated with alcohol use and engagement with treatment.

Read the detailed description

This randomized, 2x2 factorial study will enroll adults who drink alcohol regularly and are interested in reducing or stopping their alcohol use. Participants will complete four online assessments approximately four weeks apart over a 12 week study period. The assessments include questionnaires about alcohol use, suicidal thoughts and behaviors and behavioral economic decision-making.

Participants will be randomly assigned to receive access to Computer-Based Training for Cognitive Behavioral Therapy (CBT4CBT) program either immediately after the baseline assessment or after the second follow-up assessment. The study will compare participants with and without recent suicidal thoughts and behaviors to evaluate differences in decision-making, alcohol use, and engagement with the CBT4CBT program. The results may improve understanding of factors related to alcohol use and suicide risk and help inform future interventions for individuals with alcohol use concerns.

02

Conditions studied

  • Alcohol Use Disorder (AUD)
  • Suicidal Ideation
03

In context

Alcoholism

1,674 studies on the registry are indexed under Alcoholism; 331 are open to participants now.

This study's planned enrollment of 180 is above the median of 88 across 1,428 interventional studies indexed under Alcoholism.

Browse Alcoholism studies →

Lead sponsor

Mark J Rzeszutek, PhD is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Consume alcohol at least weekly
  • Score of 8 or greater on the Alcohol Use Disorder Identification Test (AUDIT)
  • Some interest in cutting back on drinking or quitting
  • Read and understand English
  • Recent active/passion ideation

Exclusion criteria

Exclusion Criteria:

  • Score of 31 or greater on the AUDIT
  • Having unmanaged psychiatric diagnoses
  • Already being in treatment for alcohol use disorder at baseline
  • Past month substance use other than cannabis or tobacco
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Recent Suicidal Thoughts/Behaviors + Immediate CBT4CBT

    Participants with recent suicidal thoughts or behaviors who receive immediate access to CBT4CBT.

    Behavioral: CBT4CBT

  • Active comparator
    Recent Suicidal Thoughts/Behaviors + Delayed CBT4CBT

    Participants with recent suicidal thoughts or behaviors who receive delayed access to CBT4CBT after the second follow-up assessment.

    Behavioral: CBT4CBT

  • Experimental
    No Recent Suicidal Thoughts/Behaviors + Immediate CBT4CBT

    Participants without recent suicidal thoughts or behaviors who receive immediate access to CBT4CBT.

    Behavioral: CBT4CBT

  • Active comparator
    No Recent Suicidal Thoughts/Behaviors + Delayed CBT4CBT

    Participants without recent suicidal thoughts or behaviors who receive delayed access to CBT4CBT after the second follow-up assessment.

    Behavioral: CBT4CBT

Interventions

  • BehavioralCBT4CBT

    Computer-Based Training for Cognitive Behavioral Therapy (CBT4CBT), a self-guided computerized cognitive behavioral therapy program for alcohol use. Participants receive access either immediately following the baseline assessment or after the second follow-up assessment.

06

What researchers measure

Primary outcomes

  1. Change in Alcohol Use

    Change in alcohol consumption measured using the 28-day Timeline Follow-Back (TLFB).

    Time frame: Baseline, 4 Weeks, 8 Weeks, and 12 Weeks.

  2. Change in Suicidal Thoughts and Behaviors

    Change in suicidal thoughts and behaviors as measured by the Colombia Suicide Severity Rating Scale (C-SSRS). Suicidal ideation severity is measured from a scale of 0 to 25, where higher scores indicate higher levels of suicidal ideation severity.

    Time frame: Baseline, 4 Weeks, 8 Weeks, and 12 Weeks.

07

Study locations

No study locations are listed for this record.

08

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2027; primary completion for Mar 2029, 24 months later.

Of 470 non-industry interventional studies with no phase under Alcoholism, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 55. This study's planned 24 months is below that.

Counting every sponsor, half of 493 studies reached it within 33 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 21, 2026
First posted
Sep 25, 2026
StartEst.
Mar 2027
Primary completionEst.
Mar 2029
CompletionEst.
Aug 2029
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionChange in Suicidal Thoughts and Behaviors: how it is measured was reworded
Nov 6, 2026
Registered
First appeared on the registry
Sep 25, 2026
Show all 2 updates
  1. Nov 6, 2026
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionChange in Suicidal Thoughts and Behaviors: how it is measured was reworded
    + 1 other change: verification date
  2. Sep 25, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07842588
Lead sponsor
Mark J Rzeszutek, PhD
Responsible party
Mark J Rzeszutek, PhD (Assistant Professor, University of Kentucky) — Sponsor-investigator
First posted
Sep 25, 2026
Start date
Mar 2027 (estimated)
Primary completion
Mar 2029 (estimated)
Completion
Aug 2029 (estimated)
Last update
Nov 6, 2026

Study contacts

Mark Rzeszutek, PhD
Contact
mark.rzeszutek@uky.edu
859-323-5264

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion